📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy. (2017)

First Author: Cureton N
Attributed to:  Use of nanoparticles to deliver growth signals to the placenta funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7150/thno.19678

PubMed Identifier: 29109771

Publication URI: http://europepmc.org/abstract/MED/29109771

Type: Journal Article/Review

Volume: 7

Parent Publication: Theranostics

Issue: 15

ISSN: 1838-7640